Oxford, UK – Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products, ensuring seamless use in combination with Oxford Nanopore’s sequencing products. The programme will expand the network of products compatible with Oxford Nanopore’s platform to enhance the overall […]
German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biopharmaceutical product development Part of Merck’s € 1.5 billion investment program in Darmstadt by 2025 DARMSTADT, GERMANY — Merck, a leading science and technology company, is investing more than € 300 million in a new research […]
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency […]
SINGAPORE — GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into GenScript’s state-of-the-art gene and protein production facility, particularly highlighting the company’s advancements in AI-driven gene […]
BOSTON, MA — In the wake of widespread media attention surrounding Colossal Biosciences’ ambitious de-extinction efforts, eLabNext, a pioneer in digital lab solutions, is proud to spotlight its instrumental role in supporting the groundbreaking research aimed at reviving the woolly mammoth. eLabNext’s flagship software, eLabJournal has been a critical tool for the management of complex data and workflows associated with Colossal Biosciences’ historic […]
The laboratory has state-of-the-art technology to support medical research of clinical labs and healthcare institutions, improving precision diagnoses and treatments. The agricultural sector can also benefit. São Paulo, Brazil – Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life […]
Parr Instrument Company has announced plans to build a 54,000 square foot facility adjacent to their existing building at the corner of 53rd Street and 4th Avenue in Moline, Illinois. The new state of the art facility will house the manufacturing operations of the company established in 1899. After completion of the new facility the […]
cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development; Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine SAN DIEGO — TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and […]
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 – $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. – PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2024. Preliminary First Quarter Results Preliminary revenue of $38.8 million, roughly flat compared with $38.9 million in the prior-year period. Instrument revenue of $19.0 million compared with $20.7 million in the prior-year […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
